首页> 外国专利> ASSOCIATION OF N-(((7S)-3,4-DIMETHOXYBICYCLO(4.2.0)OCTA-1,3,5-TRIEN-7-YL)METHYL)-3-(7,8-DIMETHOXY-1,2,4,5-TETRAHYDRO-3H-3-BENZAZEPIN-3-YL)-N-METHYL-3-OXO-1-PROPANAMINE AND PERINDOPRIL

ASSOCIATION OF N-(((7S)-3,4-DIMETHOXYBICYCLO(4.2.0)OCTA-1,3,5-TRIEN-7-YL)METHYL)-3-(7,8-DIMETHOXY-1,2,4,5-TETRAHYDRO-3H-3-BENZAZEPIN-3-YL)-N-METHYL-3-OXO-1-PROPANAMINE AND PERINDOPRIL

机译:N-(((7S)-3,4-DIMETHOXYBICYCLO(4.2.0)OCTA-1,3,5-TRIEN-7-YL)METHYL)-3-(7,8-DIMETHOXY-1,2, 4,5-四氢-3H-3-苯并ZE庚啶-3-基)-N-甲基-3-氧杂-1-丙胺和培哚普利

摘要

Combination (I) comprises a selective and specific sinusal I f(mixed sodium ion-potassium ion inward current) current inhibitor (A) and an angiotensin converting enzyme inhibitor (B). An independent claim is included for pharmaceutical compositions comprising: ivabradine, in the form of hydrochloride or its hydrate or crystalline forms, and perindopril, in the form of salt of tert-butylamine or arginine or their hydrates or crystalline forms, alone or in combination with one or more excipient. ACTIVITY : Cardiant; Cardiovascular-Gen.; Vasotropic; Antianginal; Antiarrhythmic. MECHANISM OF ACTION : Sinusal I fcurrent inhibitor; Angiotensin converting enzyme inhibitor.
机译:组合(I)包括选择性和特异的鼻窦I f(混合钠离子-钾离子流入电流)电流抑制剂(A)和血管紧张素转化酶抑制剂(B)。对于药物组合物包括独立的权利要求,所述药物组合物包含:单独的盐酸盐或与之组合的盐酸盐或其水合物或结晶形式的伊伐布雷定和叔丁胺或精氨酸的盐或其水合物或结晶形式的培哚普利。一种或多种赋形剂。活动:Cardiant;心血管创变压性抗心绞痛抗心律不整。作用机理:窦性电流抑制剂;血管紧张素转换酶抑制剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号